MP28-12 MOLECULAR MARKERS (FGFR3 MUTATION; P53 & KI-67 EXPRESSION) AND CLINICAL OUTCOME OF RADICAL CYSTECTOMY FOR BLADDER CANCER: A MULTICENTER, MULTILAB STUDY

The Journal of Urology ◽

10.1016/j.juro.2014.02.661 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Laura Mertens ◽

Tahlita Zuiverloon ◽

Yann Neuzillet ◽

Shahrokh Shariat ◽

Cheno Abas ◽

...

Keyword(s):

Bladder Cancer ◽

Molecular Markers ◽

Clinical Outcome ◽

Radical Cystectomy ◽

Ki 67 ◽

Download Full-text

Molecular markers (FGFR3 mutation; p53 and Ki-67 expression) and clinical outcome of radical cystectomy for bladder cancer: A multi-center, multi-laboratory study

European Urology Supplements ◽

10.1016/s1569-9056(19)30597-4 ◽

2019 ◽

Vol 18 (1) ◽

pp. e819

Author(s):

B.W.G. Van Rhijn ◽

L. Mertens ◽

R. Mayr ◽

P. Bostrom ◽

S.F. Shariat ◽

...

Keyword(s):

Bladder Cancer ◽

Molecular Markers ◽

Clinical Outcome ◽

Radical Cystectomy ◽

Laboratory Study ◽

Ki 67 ◽

Download Full-text

Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.10.010 ◽

2021 ◽

Author(s):

Laura S. Mertens ◽

Francesco Claps ◽

Roman Mayr ◽

Peter J. Bostrom ◽

Shahrokh F. Shariat ◽

...

Keyword(s):

Bladder Cancer ◽

Radical Cystectomy ◽

Prognostic Markers ◽

Laboratory Analysis ◽

Invasive Bladder Cancer ◽

Ki 67 ◽

Mutation Status ◽

Download Full-text

52 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER

European Urology Supplements ◽

10.1016/s1569-9056(10)60060-7 ◽

2010 ◽

Vol 9 (2) ◽

pp. 50

Author(s):

B.W.G. Van Rhijn ◽

T.H. Van Der Kwast ◽

B. Bapat ◽

P.J. Bostrom ◽

N.E. Fleshner ◽

...

Keyword(s):

Bladder Cancer ◽

Molecular Markers ◽

Clinical Outcome ◽

Download Full-text

Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens

BJU International ◽

10.1046/j.1464-410x.1997.02710.x ◽

1997 ◽

Vol 79 (3) ◽

pp. 367-372 ◽

Author(s):

M. Tsuji ◽

K. Kojima ◽

Y. Murakami ◽

H. Kanayama ◽

S. Kagawa

Keyword(s):

Bladder Cancer ◽

Urinary Bladder ◽

Radical Cystectomy ◽

Prognostic Value ◽

P53 Protein ◽

Immunohistochemical Analysis ◽

Urinary Bladder Cancer ◽

Download Full-text

765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER

European Urology Supplements ◽

10.1016/s1569-9056(11)60753-7 ◽

2011 ◽

Vol 10 (2) ◽

pp. 243 ◽

Author(s):

B.W.G. Van Rhijn ◽

P.J. Bostrom ◽

S.F. Shariat ◽

A. Finelli ◽

A.I. Sagalowsky ◽

...

Keyword(s):

Bladder Cancer ◽

Radical Cystectomy ◽

Download Full-text

Abstract B23: FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?

10.1158/1557-3265.bladder19-b23 ◽

2020 ◽

Author(s):

Bas van Rhijn ◽

Laura Mertens ◽

Roman Mayr ◽

Peter Bostrom ◽

Mirari Marques ◽

...

Keyword(s):

Bladder Cancer ◽

Clinical Outcome ◽

Cancer Treatment ◽

Radical Cystectomy ◽

Fgfr3 Mutations

Download Full-text

1714 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2010.02.1561 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Bas van Rhijn ◽

Theo van der Kwast ◽

Bharati Bapat ◽

Peter Bostrom ◽

Neil Fleshner ◽

...

Keyword(s):

Bladder Cancer ◽

Molecular Markers ◽

Clinical Outcome ◽

Download Full-text

The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.01.007 ◽

2021 ◽

Author(s):

Michel D. Wissing ◽

Ana O'Flaherty ◽

Alice Dragomir ◽

Simon Tanguay ◽

Wassim Kassouf ◽

...

Keyword(s):

Bladder Cancer ◽

Clinical Outcome ◽

Radical Cystectomy ◽

Reductase Inhibitors ◽

Male Patients ◽

5 Alpha Reductase Inhibitors ◽

Improve Clinical Outcome

Download Full-text

Abstract 4902: Positive Ki-67 expression in post neoadjuvant chemotherapy (NAC) radical cystectomy samples are associated with lack of tumor downstaging and shorter overall survival (OS) in patients with muscle invasive bladder cancer (MIBC)

10.1158/1538-7445.am2019-4902 ◽

2019 ◽

Author(s):

Selene Rubino ◽

Youngchul Kim ◽

Junmin Zhou ◽

Charles Peyton ◽

Scott Gilbert ◽

...

Keyword(s):

Overall Survival ◽

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Radical Cystectomy ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Ki 67 ◽

Tumor Downstaging ◽

Muscle Invasive

Download Full-text

FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?

European Urology Supplements ◽

10.1016/s1569-9056(19)31045-0 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1450-e1451

Author(s):

L.S. Mertens ◽

B.W.G. Van Rhijn ◽

R. Mayr ◽

P.J. Bostrom ◽

M. Marquez ◽

...

Keyword(s):

Bladder Cancer ◽

Clinical Outcome ◽

Cancer Treatment ◽

Radical Cystectomy ◽

Fgfr3 Mutations

Download Full-text